Roche has filed obinutuzumab on both sides of the Atlantic to treat chronic lymphocytic leukaemia.May 16, 2013
read all at
http://newdrugapprovals.wordpress.com/2013/05/17/roche-files-next-generation-rituxan-in-usa-eu/
Friday 17 May 2013
Roche has filed obinutuzumab on both sides of the Atlantic to treat chronic lymphocytic leukaemia.
Roche has filed obinutuzumab on both sides of the Atlantic to treat chronic lymphocytic leukaemia.May 16, 2013
read all at
http://newdrugapprovals.wordpress.com/2013/05/17/roche-files-next-generation-rituxan-in-usa-eu/
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment